New Leaf Ventures Ii, L.p. - Net Worth and Insider Trading
New Leaf Ventures Ii, L.p. Net Worth
The estimated net worth of New Leaf Ventures Ii, L.p. is at least $193 Million dollars as of 2024-11-12. New Leaf Ventures Ii, L.p. is the 10% Owner of iRhythm Technologies Inc and owns about 1,741,589 shares of iRhythm Technologies Inc (IRTC) stock worth over $152 Million. New Leaf Ventures Ii, L.p. is the 10% Owner of Principia Biopharma Inc and owns about 387,546 shares of Principia Biopharma Inc (PRNB) stock worth over $39 Million. New Leaf Ventures Ii, L.p. is also the 10% Owner of Chimerix Inc and owns about 2,243,394 shares of Chimerix Inc (CMRX) stock worth over $2 Million. Besides these, New Leaf Ventures Ii, L.p. also holds MEI Pharma Inc (MEIP) . Details can be seen in New Leaf Ventures Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that New Leaf Ventures Ii, L.p. has not made any transactions after 2019-08-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of New Leaf Ventures Ii, L.p.
New Leaf Ventures Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Leaf Ventures Ii, L.p. owns 7 companies in total, including Principia Biopharma Inc (PRNB) , Neuronetics Inc (STIM) , and iRhythm Technologies Inc (IRTC) among others .
Click here to see the complete history of New Leaf Ventures Ii, L.p.’s form 4 insider trades.
Insider Ownership Summary of New Leaf Ventures Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2019-08-13 | 10 percent owner |
| STIM | Neuronetics Inc | 2018-06-27 | 10 percent owner |
| IRTC | iRhythm Technologies Inc | 2016-10-25 | 10 percent owner |
 | | 2015-03-24 | 10 percent owner |
| | 2014-03-20 | director & 10 percent owner |
| | 2013-10-23 | 10 percent owner |
| | 2013-11-27 | director & other: Former 10% Beneficial Owner |
New Leaf Ventures Ii, L.p. Latest Holdings Summary
New Leaf Ventures Ii, L.p. currently owns a total of 4 stocks. Among these stocks, New Leaf Ventures Ii, L.p. owns 1,741,589 shares of iRhythm Technologies Inc (IRTC) as of October 25, 2016, with a value of $152 Million and a weighting of 78.74%. New Leaf Ventures Ii, L.p. owns 387,546 shares of Principia Biopharma Inc (PRNB) as of August 13, 2019, with a value of $39 Million and a weighting of 20.1%. New Leaf Ventures Ii, L.p. also owns 2,243,394 shares of Chimerix Inc (CMRX) as of October 23, 2013, with a value of $2 Million and a weighting of 1.15%. The other 1 stocks MEI Pharma Inc (MEIP) have a combined weighting of 0% among all his current holdings.
Latest Holdings of New Leaf Ventures Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRTC | iRhythm Technologies Inc | 2016-10-25 | 1,741,589 | 87.20 | 151,866,561 |
| PRNB | Principia Biopharma Inc | 2019-08-13 | 387,546 | 100.05 | 38,773,977 |
| CMRX | Chimerix Inc | 2013-10-23 | 2,243,394 | 0.99 | 2,226,344 |
| MEIP | MEI Pharma Inc | 2015-03-24 | 0 | 3.14 | 0 |
Holding Weightings of New Leaf Ventures Ii, L.p.
New Leaf Ventures Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, New Leaf Ventures Ii, L.p. has made a total of 0 transactions in iRhythm Technologies Inc (IRTC) over the past 5 years. The most-recent trade in iRhythm Technologies Inc is the acquisition of 25,000 shares on October 25, 2016, which cost New Leaf Ventures Ii, L.p. around $425,000.
According to the SEC Form 4 filings, New Leaf Ventures Ii, L.p. has made a total of 0 transactions in Principia Biopharma Inc (PRNB) over the past 5 years. The most-recent trade in Principia Biopharma Inc is the sale of 300,000 shares on August 13, 2019, which brought New Leaf Ventures Ii, L.p. around $11 Million.
According to the SEC Form 4 filings, New Leaf Ventures Ii, L.p. has made a total of 0 transactions in Chimerix Inc (CMRX) over the past 5 years. The most-recent trade in Chimerix Inc is the sale of 585,602 shares on October 23, 2013, which brought New Leaf Ventures Ii, L.p. around $9 Million.
More details on New Leaf Ventures Ii, L.p.'s insider transactions can be found in the Insider Trading History of New Leaf Ventures Ii, L.p. table.Insider Trading History of New Leaf Ventures Ii, L.p.
- 1
New Leaf Ventures Ii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of New Leaf Ventures Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Leaf Ventures Ii, L.p. is 5.77%. GuruFocus also compares New Leaf Ventures Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by New Leaf Ventures Ii, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how New Leaf Ventures Ii, L.p.'s insider trading performs compared to the benchmark.
Performance of New Leaf Ventures Ii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.67 | | | | | |
| Relative Return to S&P 500(%) | -4.98 | | | | | |
New Leaf Ventures Ii, L.p. Ownership Network
Ownership Network List of New Leaf Ventures Ii, L.p.
Ownership Network Relation of New Leaf Ventures Ii, L.p.
New Leaf Ventures Ii, L.p. Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
New Leaf Ventures Ii, L.p. is the 10 percent owner of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
New Leaf Ventures Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for New Leaf Ventures Ii, L.p.. You might contact New Leaf Ventures Ii, L.p. via mailing address: 420 Lexington Avenue, Suite 408, New York Ny 10170.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
